Article

Randomised Clinical Trial to Evaluate Safety and Efficacy of Convalescent Plasma Use Among Hospitalized Patients with COVID-19 (PERUCONPLASMA): A Structured Summary af a Study Protocol for a Randomised Controlled Trial.

2021-03-15

Abstract excerpt

<title>Abstract</title> <p>Objectives The general objective of this study is to test the hypothesis that administration of convalescent plasma from donors with previous diagnosis of severe COVID-19 pneumonia is safe and associated with a decrease in all-cause in-hospital mortality among hospitalized patients with COVID-19 at 30 days in comparison with standard treatment alone. The secondary objectives are: 1) to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 178022cc-4a53-5c33-8bf0-f15d3e4a3bb6
DOI: 10.21203/rs.3.rs-317097/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Randomised Clinical Trial to Evaluate Safety and Efficacy of Convalescent Plasma Use Among Hospitalized Patients with COVID-19 (PERUCONPLASMA): A Structured Summary af a Study Protocol for a Randomised Controlled Trial.DOI 10.21203/rs.3.rs-317097/v1Read

COVID-19 convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized trialSemantic proximity Read

A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19Semantic proximity Read

Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)Semantic proximity Read

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide EvidenceSemantic proximity Read

Efficacy and safety of convalescent plasma therapy for severe COVID-19 patients：case series study and literature reviewSemantic proximity Read

COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacySemantic proximity Read

Timing of convalescent plasma administration and 28-day mortality for COVID-19 pneumoniaSemantic proximity Read

On Whether Therapeutic Plasma Exchange is Effective Against Severe/Critical COVID-19 PneumoniaSemantic proximity Read

COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized TrialsSemantic proximity Read

Treatment of COVID-19 Patients with Convalescent Plasma in Houston, TexasSemantic proximity Read

On whether therapeutic plasma exchange is an effective cure against severe/critical COVID-19 pneumoniaSemantic proximity Read

Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community SettingSemantic proximity Read